✦ LIBER ✦

CN2 COST-UTILITY ANALYSIS OF LHRH AGONISTS IN THE TREATMENT OF METASTATIC PROSTATE CANCER

✍ Scribed by M Hemels; M Iskedjian; N Iscoe; N Fleshner; T Einarson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN8 COST-EFFECTIVENESS ANALYSIS OF LHRH

✍ M Iskedjian; M Hemels; N Iscoe; N Fleshner; T Einarson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Cost-effectiveness analysis of LHRH agon

✍ S. Iannazzo; L. Pradelli; M. Carsi; M. Perachino 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 981 KB

Prostate cancer: Interpreting cost-utili

✍ Yu, James B. 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Cost Utility Analysis of Everolimus in t

✍ Mihajlović, J.; Minović, I.; Bruinsma, A.; Postma, M.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Bone loss associated with the use of LHR

✍ Peters, J L; Fairney, A; Kyd, P; Patel, A; Rogers, S; Webster, J J; Vale, J A; W 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Role of Luteinising Hormone Releasing Ho

✍ P. Mongiat-Artus; P. Teillac 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 291 KB